OnBioVC

Your Source for BioScience Venture Capital Data
Lijit Search

  • OnBioVC NEWS:

    - OnBioVC Announces Beta Launch of Service
    - OnBioVC INDEX(TM) Updated thru JUN 2010
    - OnBioVC 2Q10 Trend Analysis, now available
    - OnBioVC 3Q10 Trend Analysis, coming soon

  • SEARCH THE OnBioVC DATABASE:

  • investment bank middle market venture capital

29

Mar

2010

Genetix Pharmaceuticals, Inc.: Series B $35M

Posted in I - Series B, Q - 1Q10, R - NORTH EAST, X - ALD, X - Gene Therapy, XX - MA

Genetix Pharmaceuticals (Cambridge, MA) a clinical-stage gene therapy company whose lentiviral technology is focused upon severe genetic disorders such as adrenoleukodystrophy and beta-thalassemia, closed a $35M Series B financijng. Participants include Third Rock Ventures, Genzyme Ventures, TVM Capital, Forbion and Easton Capital.

02

Nov

2009

Celladon, Inc.: Series C $21.8M

Posted in I - Series C, Q - 3Q09, R - WEST, X - Cardiology, X - Gene Therapy, XX - CA

Celladon (La Jolla, CA) a clinical-stage company focused on gene therapy for congestive heart failure, closed a $21.8M Series C financing. Participants include Enterprise Partners Venture Capital, Venrock and Johnson & Johnson Dev Corp.

  

to top of page...


 

© 2009 OnBioVC An Indicium Data, LLC Company powered by WordPress